Skip to content
    FB

    Fidelity Biosciences

    Cambridge, Massachusetts, United States
    Biotech & Life Sciences

    Fidelity Biosciences merged with Devonshire Investors' technology venture capital fund in October 2015 to become F-Prime Capital. F-Prime Capital is a global venture capital firm that invests in life sciences, healthcare, and technology companies, with a focus on innovative early-stage companies.

    Find people at Fidelity Biosciences on Goldilocks AI

    Portfolio

    1

    Fund Size

    —

    Top Stage

    Unknown

    Last 12 Mo

    0

    Stage Distribution

    Portfolio

    1 investment
    CompanyRoundAmountDate
    Denali TherapeuticsUnknown—May 2015

    Top Co-Investors

    ARCH Venture Partners1 shared
    Flagship Ventures1 shared
    Alaska Permanent Fund1 shared

    Last updated: 3 March 2026